Your browser doesn't support javascript.
loading
Intratumoral heterogeneity and clonal evolution in liver cancer.
Losic, Bojan; Craig, Amanda J; Villacorta-Martin, Carlos; Martins-Filho, Sebastiao N; Akers, Nicholas; Chen, Xintong; Ahsen, Mehmet E; von Felden, Johann; Labgaa, Ismail; DʹAvola, Delia; Allette, Kimaada; Lira, Sergio A; Furtado, Glaucia C; Garcia-Lezana, Teresa; Restrepo, Paula; Stueck, Ashley; Ward, Stephen C; Fiel, Maria I; Hiotis, Spiros P; Gunasekaran, Ganesh; Sia, Daniela; Schadt, Eric E; Sebra, Robert; Schwartz, Myron; Llovet, Josep M; Thung, Swan; Stolovitzky, Gustavo; Villanueva, Augusto.
Afiliação
  • Losic B; Department of Genetics and Genomic Sciences, Cancer Immunology Program, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Craig AJ; Icahn Institute for Data Science and Genomic Technology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Villacorta-Martin C; Diabetes, Obesity and Metabolism Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Martins-Filho SN; Division of Liver Diseases, Department of Medicine, Liver Cancer Program, Tisch Cancer Institute, Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Akers N; Division of Liver Diseases, Department of Medicine, Liver Cancer Program, Tisch Cancer Institute, Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Chen X; Division of Liver Diseases, Department of Medicine, Liver Cancer Program, Tisch Cancer Institute, Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Ahsen ME; Department of Pathology, University of Sao Paulo School of Medicine, Sao Paulo, Brazil.
  • von Felden J; Department of Genetics and Genomic Sciences, Cancer Immunology Program, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Labgaa I; Adaptive Biotechnologies, Seattle, WA, USA.
  • DʹAvola D; Department of Genetics and Genomic Sciences, Cancer Immunology Program, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Allette K; Department of Genetics and Genomic Sciences, Cancer Immunology Program, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Lira SA; Division of Liver Diseases, Department of Medicine, Liver Cancer Program, Tisch Cancer Institute, Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Furtado GC; I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Garcia-Lezana T; Division of Liver Diseases, Department of Medicine, Liver Cancer Program, Tisch Cancer Institute, Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Restrepo P; Department of Visceral Surgery, Lausanne University Hospital CHUV, Lausanne, Switzerland.
  • Stueck A; Division of Liver Diseases, Department of Medicine, Liver Cancer Program, Tisch Cancer Institute, Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Ward SC; Liver Unit and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Clínica Universidad de Navarra, Pamplona, Spain.
  • Fiel MI; Department of Genetics and Genomic Sciences, Cancer Immunology Program, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Hiotis SP; Icahn Institute for Data Science and Genomic Technology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Gunasekaran G; Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Sia D; Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Schadt EE; Division of Liver Diseases, Department of Medicine, Liver Cancer Program, Tisch Cancer Institute, Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Sebra R; Department of Genetics and Genomic Sciences, Cancer Immunology Program, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Schwartz M; Department of Pathology, Dalhousie University, Halifax, NS, Canada.
  • Llovet JM; Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Thung S; Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Stolovitzky G; Department of Surgery, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Villanueva A; Department of Surgery, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Nat Commun ; 11(1): 291, 2020 01 15.
Article em En | MEDLINE | ID: mdl-31941899
Clonal evolution of a tumor ecosystem depends on different selection pressures that are principally immune and treatment mediated. We integrate RNA-seq, DNA sequencing, TCR-seq and SNP array data across multiple regions of liver cancer specimens to map spatio-temporal interactions between cancer and immune cells. We investigate how these interactions reflect intra-tumor heterogeneity (ITH) by correlating regional neo-epitope and viral antigen burden with the regional adaptive immune response. Regional expression of passenger mutations dominantly recruits adaptive responses as opposed to hepatitis B virus and cancer-testis antigens. We detect different clonal expansion of the adaptive immune system in distant regions of the same tumor. An ITH-based gene signature improves single-biopsy patient survival predictions and an expression survey of 38,553 single cells across 7 regions of 2 patients further reveals heterogeneity in liver cancer. These data quantify transcriptomic ITH and how the different components of the HCC ecosystem interact during cancer evolution.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Evolução Clonal / Neoplasias Hepáticas Limite: Humans Idioma: En Revista: Nat Commun Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Evolução Clonal / Neoplasias Hepáticas Limite: Humans Idioma: En Revista: Nat Commun Ano de publicação: 2020 Tipo de documento: Article